4-Nonylphenol triggers apoptosis and affects 17-β-Estradiol receptors in calvarial osteoblasts

Toxicology

Volumn 290, Issue 2-3, 2011, Pages 334-341

  Sabbieti, Maria Giovanna ^a   Agas, Dimitrios ^a   Palermo, Francesco ^a   Mosconi, Gilberto ^a   Santoni, Giorgio ^a   Amantini, Consuelo ^a   Farfariello, Valerio ^a   Marchetti, Luigi ^a  

^a UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Alkylphenols; Apoptosis; Osteoblasts

Indexed keywords

4 NONYLPHENOL; CASPASE 8; ESTRADIOL RECEPTOR; PHOSPHATIDYLSERINE; PROTEIN BAX; PROTEIN BCL 2;

ANIMAL CELL; APOPTOSIS; ARTICLE; CALVARIA; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; MALE; MOLECULAR INTERACTION; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION;

EID: 84858615570     PISSN: 0300483X     EISSN: 18793185     Source Type: Journal    
DOI: 10.1016/j.tox.2011.10.014     Document Type: Article

References (56)

1. Agas D., Sabbieti M.G., Capacchietti M., Materazzi S., Menghi G., Materazzi G., Hurley M.M., Marchetti L. Benzyl butyl phthalate influences actin distribution and cell proliferation in rat Py1a osteoblasts. J. Cell. Biochem. 2007, 101:543-551.
2. Amantini C., Ballarini P., Caprodossi S., Nabissi M., Morelli M.B., Lucciarini R., Cardarelli M.A., Mammana G., Santoni G. Triggering of transient receptor potential vanilloid type 1 (TRPV1) by capsaicin induces Fas/CD95-mediated apoptosis of urothelial cancer cells in an ATM-dependent manner. Carcinogenesis 2009, 30:1320-1329.
3. Adeoya-Osiguwa S.A., Markoulaki S., Pocock V., Milligan S.R., Fraser L.R. 17beta-Estradiol and environmental estrogens significantly affect mammalian sperm function. Hum. Reprod. 2003, 18:100-107.
4. Bellido T., Girasole G., Passeri G., Yu X.P., Mocharla H., Jilka R.L., Notides A., Manolagas S.C. Demonstration of estrogen and vitamin D receptors in bone-marrow-derived stromal cells: up-regulation of the estrogen receptor by 1,25-dihydroxyvitamin-D3. Endocrinology 1993, 133:553-562.
5. Blume B., Kietzmann M., Kranke P., Moder M., Schrader S., Wahren M. Deuterium labelled nonylphenols in an in vitro model of percutaneous absorption of environmental xenoestrogens. Environ. Health Stud. 2000, 36:3-9.
6. Bodine P.V., Henderson R.A., Green J., Aronow M., Owen T., Stein G.S., Lian J.B., Komm B.S. Estrogen receptor-alpha is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 1998, 139:2048-2057.
7. Bord S., Ireland D.C., Beavan S.R., Compston J.E. The effects of estrogen on osteoprotegerin RANKL, and estrogen receptor expression in human osteoblasts. Bone 2003, 32:136-141.
8. Braidman I.P., Hainey L., Batra G., Selby P.L., Saunders P.T., Hoyland J.A. Localization of estrogen receptor beta protein expression in adult human bone. J. Bone Miner. Res. 2001, 16:214-220.
9. Bresford J.N., Graves S.E., Smoothy C.A. Formation of mineralized nodules by bone derived cells in vitro: a model of bone formation?. Am. J. Med. Genet. 1993, 45:163-178.
10. Chapin R.E., Delaney J., Wang Y., Lanning L., Davis B., Collins B., Mintz N., Wolfe G. The effects of 4-nonylphenol in rats: a multigeneration reproduction study. Toxicol. Sci. 1999, 52:80-91.
11. Chau J.F., Leong W.F., Li B. Signaling pathways governing osteoblast proliferation, differentiation and function. Histol. Histopathol. 2009, 24:1593-1606.
12. Clotfelter E.D., Bell A.M., Levering K.R. The role of animal behaviour in the study of endocrine-disrupting chemicals. Anim. Behav. 2004, 68:665-676.
13. Danzo B.J., Shappell H.W., Banerjee A., Hachey D.L. Effects of nonylphenol, 1,1-dichloro-2,2-bis(p-chlorophenyl) ethylene (p,p'-DDE), and pentachlorophenol on the adult female guinea pig reproductive tract. Reprod. Toxicol. 2002, 16:29-43.
14. Desagher S., Osen-Sand A., Nichols A., Eskes R., Montessuit S., Lauper S., Maundrell K., Antonsson B., Martinou J.C. Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J. Cell Biol. 1999, 144:891-901.
15. Erdjument-Bromage H., Tempst P., Korsmeyer S.J. Caspase cleaved bid targets mitochondria and is required for cytochrome c release while BCL-XL prevents this release but not tumor necrosis factor-R1/Fas death. J. Biol. Chem. 1999, 274:1156-1163.
16. Ernst M., Heath J.K., Schmid C., Froesch R.E., Rodan G.A. Evidence for a direct effect of estrogen on bone cells in vitro. J. Steroid. Biochem. 1989, 34:279-284.
17. Eskes R., Desagher S., Antonsson B., Martinou J.C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell. Biol. 2000, 20:929-935.
18. Fang H., Tong W., Shi L.M., Blair R., Perkins R., Branham W., Hass B.S., Xie Q., Dial S.L., Moland C.L., Sheehan D.M. Structure-activity relationships for a large diverse set of natural, synthetic, and environmental estrogens. Chem. Res. Toxicol. 2001, 14:280-294.
19. Gruber R., Czerwenka K., Wolf F., Ho G.M., Willheim M., Peterlik M. Expression of the Vitamin D Receptor, of Estrogen and Thyroid Hormone Receptor a- and b-Isoforms, and of the Androgen Receptor in Cultures of Native Mouse Bone Marrow and of Stromal/Osteoblastic Cells. Bone 1999, 24:465-473.
20. Hagiwara H., Sugizakia T., Tsukamoto Y., Senoh E., Goto T., Ishihara Y. Effects of alkylphenols on bone metabolism in vivo and in vitro. Toxicol. Lett. 2008, 18:13-18.
21. Ikegami A., Inoue S., Hosoi T., Mizuno Y., Nakamura T., Ouchi Y., Orimo H. Immunohistochemical detection and northern blot analysis of estrogen receptor in osteoblastic cells. J. Bone Miner. Res. 1993, 8:1103-1109.
22. Inoue A., Hiruma Y., Hirose S., Yamaguchi A., Furuya M., Tanaka S., Hagiwara H. Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells. Biochem. Biophys. Res. Commun. 1996, 221:703-707.
23. Kameda T., Mano H., Yuasa T., Mori Y., Miyazawa K., Shiokawa M., Nakamaru Y., Hiroi E., Hiura K., Kameda A., Yang N.N., Hakeda Y., Kumegawa M. Estrogen inhibits bone resorption by directly inducing apoptosis of the bone-resorbing osteoclasts. J. Exp. Med. 1997, 186:489-495.
24. Khalid O., Baniwal S.K., Purcell D.J., Leclerc N., Gabet Y., Stallcup M.R., Coetzee G.A., Frenkel B. Modulation of Runx2 activity by estrogen receptor-alpha: implications for osteoporosis and breast cancer. Endocrinology 2008, 149:5984-5995.
25. Kanno S., Hirano S., Kayama F. Effects of phytoestrogens and environmental estrogens on osteoblastic differentiation in MC3T3-E1 cells. Toxicology 2004, 196:137-145.
26. Kavlock R.J., Daston G.P., DeRosa C., Fenner-Crisp P., Gray L.E., Kaattari S., Lucier G., Luster M., Mac M.J., Maczka C., Miller R., Moore J., Rolland R., Scott G., Sheehan D.M., Sinks T., Tilson H.A. Research needs for the risk assessment of health and environmental effects of endocrine disruptors: a report of the U.S. EPA-sponsored workshop. Environ. Health Perpect. 1996, 104:715-740.
27. Kousteni S., Chen J.R., Bellido T., Han L., Ali A.A., O'Brien C.A., Plotkin L., Fu Q., Mancino A.T., Wen Y., Vertino A.M., Powers C.C., Stewart S.A., Ebert R., Parfitt A.M., Weinstein R.S., Jilka R.L., Manolagas S.C. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science 2002, 298:843-846.
28. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
29. Luk J.M., Kongmuang U., Tsang R.S., Lindberg A.A. An enzyme-linked immunosorbent assay to detect PCR products of the rfbS gene from serogroup D salmonellae: a rapid screening prototype. J. Clin. Microbiol. 1997, 35:714-718.
30. Marchetti L., Sabbieti M.G., Menghi M., Materazzi S., Hurley M.M., Menghi G. Effects of phthalate esters on actin cytoskeleton of Py1a rat osteoblasts. Histol. Histopathol. 2002, 17:1061-1066.
31. Markey C.M., Rubin B.S., Soto A.M., Sonnenschein C. Endocrine disruptors: from Wingspread to environmental developmental biology. J. Steroid Biochem. Mol. Biol. 2003, 83:235-244.
32. Masuyama H., Hiramatsu Y., Kunitomi M., Kudo T., MacDonald P.N. Endocrine disrupting chemicals, phthalic acid and nonylphenol, activate Pregnane X receptor-mediated transcription. Mol. Endocrinol. 2000, 14:421-428.
33. Matsumoto Y., Otsuka F., Takano M., Mukai T., Yamanaka R., Takeda M., Miyoshi T., Inagaki K., Sada K.E., Makino H. Estrogen and glucocorticoid regulate osteoblast differentiation through the interaction of bone morphogenetic protein-2 and tumor necrosis factor-alpha in C2C12 cells. Mol. Cell. Endocrinol. 2010, 325:118-127.
34. Miyawaki J., Kamei S., Sakayama K., Yamamoto H., Masuno H. 4-Tert-octylphenol regulates the differentiation of C3H10T1/2 cells into osteoblast and adipocyte lineages. Toxicol. Sci. 2008, 102:82-88.
35. Montero A., Okada Y., Tomita M., Ito M., Tsurukami H., Nakamura T., Doetschman T., Coffin J.D., Hurley M.M. Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation. J. Clin. Invest. 2000, 105:1085-1093.
36. Mueller G.C., Kim U.H. Displacement of estradiol from estrogen receptors by simple alkyl phenols. Endocrinology 1978, 102:1429-1435.
37. Nimrod A.C., Benson W.H. Environmental estrogenic effects of alkylphenol ethoxylates. Crit. Rev. Toxicol. 1996, 69:335-364.
38. Notoya M., Tsukamoto Y., Nishimura H., Woo J.T., Nagai K., Lee I.S., Hagiwara H. Quercetin, a flavonoid, inhibits the proliferation, differentiation, and mineralization of osteoblasts in vitro. Eur. J. Pharmacol. 2004, 485:89-96.
39. Notoya M., Nishimura H., Woo J.T., Nagai K., Ishihara Y., Hagiwara H. Curcumin inhibits the proliferation and mineralization of cultured osteoblasts. Eur. J. Pharmacol. 2006, 534:55-62.
40. Odum J., Pyrah I.T., Foster J.R., Van Miller J.P., Joiner R.L., Ashby J. Comparative activities of p-nonylphenol and diethylstilbestrol in noble rat mammary gland and uterotrophic assays. Regul. Toxicol. Pharmacol. 1999, 29:184-195.
41. Qu Q., Perälä-Heape M., Kapanen A., Dahllund J., Salo J., Väänänen H.K., Härkönen P. Estrogen enhances differentiation of osteoblasts in mouse bone marrow culture. Bone 1998, 22:201-209.
42. Rhind S.M., Kyle C.E., Mackie C., McDonald L. Accumulation of endocrine disrupting compounds in sheep fetal and maternal liver tissue following exposure to pastures treated with sewage sludge. J. Environ. Monit. 2009, 11:1469-1476.
43. Rhind S.M., Kyle C.E., Mackie C., McDonald L., Zhang Z., Duff E.I., Bellingham M., Amezaga M.R., Mandon-Pepin B., Loup B., Cotinot C., Evans N.P., Sharpe R.M., Fowler P.A. Maternal and fetal tissue accumulation of selected endocrine disrupting compounds (EDCs) following exposure to sewage sludge-treated pastures before or after conception. J. Environ. Monit. 2010, 5:1582-1593.
44. Riggs B.L., Khosla S., Melton L.J. A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J. Bone Miner. Res. 1998, 13:763-773.
45. Sabbieti M.G., Agas D., Santoni G., Materazzi S., Menghi G., Marchetti L. Involvement of p53 in phthalate effects on mouse and rat osteoblasts. J. Cell. Biochem. 2009, 107:316-327.
46. Shen Y., White E. p-53 dependent apoptosis pathways. Adv. Cancer Res. 2001, 82:55-84.
47. Smith E.P., Boyd J., Frank G.R., Takahashi H., Cohen R.M., Specke B., Williams T.C., Lubahn D.B., Korach K.S. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 1994, 331:1056-1061.
48. Stein G.S., Lian J.B., Owen T.A. Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J. 1990, 4:11-23.
49. 2+ independent cell death in human osteosarcoma cells. Toxicol. Lett. 2005, 160:76-83.
50. Weitzmann M.N., Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J. Clin. Invest. 2006, 116:1186-1194.
51. White R., Jobling S., Hoare S.A., Sumpter J.P., Parker M.G. Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 1994, 135:175-182.
52. Windahl S.H., Andersson G., Gustafsson J.A. Elucidation of estrogen receptor function in bone with the use of mouse models. Trends Endocrinol. Metab. 2002, 13:195-200.
53. Yamagishi T., Otsuka E., Hagiwara H. Reciprocal control of expression of mRNAs for osteoclast differentiation factor and osteoprotegerin in osteogenic stromal cells by genistein: evidence for the involvement of topoisomerase II in osteoclastogenesis. Endocrinology 2001, 142:3632-3637.
54. Yin X.M., Wang K., Gross A., Zhao Y., Zinkel S., Klocke B., Roth K.A., Korsmeyer S.J. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature 1999, 400:886-891.
55. Yuhara S., Kasagi S., Inoue A., Otsuka E., Hirose S., Hagiwara H. The effects of nicotine on cultured cells suggest that it can influence the formation and resorption of bone. Eur. J. Pharmacol. 1999, 383:387-393.
56. Zallone A. Direct and indirect estrogen actions on osteoblasts and osteoclasts. Ann. N.Y. Acad. Sci. 2006, 1068:173-179.